Evidence map›Paper›PMID 24971578›Full record

ArticlePloS one2014

MutLα heterodimers modify the molecular phenotype of Friedreich ataxia.

Vahid Ezzatizadeh, Chiranjeevi Sandi, Madhavi Sandi, Sara Anjomani-Virmouni, Sahar Al-Mahdawi, Mark A Pook

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Genetic modifiers of repeat expansion disorders.Emerging topics in life sciences · 2023
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Vahid EzzatizadehDivision of Biosciences, School of Health Sciences and Social Care, Brunel University London, Uxbridge, United Kingdom.
Chiranjeevi SandiDivision of Biosciences, School of Health Sciences and Social Care, Brunel University London, Uxbridge, United Kingdom.
Madhavi SandiDivision of Biosciences, School of Health Sciences and Social Care, Brunel University London, Uxbridge, United Kingdom.
Sara Anjomani-VirmouniDivision of Biosciences, School of Health Sciences and Social Care, Brunel University London, Uxbridge, United Kingdom.
Sahar Al-MahdawiDivision of Biosciences, School of Health Sciences and Social Care, Brunel University London, Uxbridge, United Kingdom.
Mark A PookDivision of Biosciences, School of Health Sciences and Social Care, Brunel University London, Uxbridge, United Kingdom.
Brunel University of London · GB

Funding

Wellcome TrustWellcome Trust 089757
6 · The paper itself

Abstract

backgroundFriedreich ataxia (FRDA), the most common autosomal recessive ataxia disorder, is caused by a dynamic GAA repeat expansion mutation within intron 1 of FXN gene, resulting in down-regulation of frataxin expression. Studies of cell and mouse models have revealed a role for the mismatch repair (MMR) MutS-heterodimer complexes and the PMS2 component of the MutLα complex in the dynamics of intergenerational and somatic GAA repeat expansions: MSH2, MSH3 and MSH6 promote GAA repeat expansions, while PMS2 inhibits GAA repeat expansions. METHODOLOGY/PRINCIPAL

findingsTo determine the potential role of the other component of the MutLα complex, MLH1, in GAA repeat instability in FRDA, we have analyzed intergenerational and somatic GAA repeat expansions from FXN transgenic mice that have been crossed with Mlh1 deficient mice. We find that loss of Mlh1 activity reduces both intergenerational and somatic GAA repeat expansions. However, we also find that loss of either Mlh1 or Pms2 reduces FXN transcription, suggesting different mechanisms of action for Mlh1 and Pms2 on GAA repeat expansion dynamics and regulation of FXN transcription. CONCLUSIONS/SIGNIFICANCE: Both MutLα components, PMS2 and MLH1, have now been shown to modify the molecular phenotype of FRDA. We propose that upregulation of MLH1 or PMS2 could be potential FRDA therapeutic approaches to increase FXN transcription.

Indexed as

Adaptor Proteins, Signal TransducingAdenosine TriphosphatasesAnimalsCell LineDimerizationDNA-Binding ProteinsDNA Mismatch RepairDNA Repair EnzymesFrataxinFriedreich AtaxiaGenomic InstabilityHCT116 CellsHumansIron-Binding ProteinsMiceMice, Inbred C57BLAdaptor Proteins, Signal TransducingAdenosine TriphosphatasesDNA-Binding ProteinsDNA Repair EnzymesFrataxinIron-Binding ProteinsMismatch Repair Endonuclease PMS2Mlh1 protein, mouseMutLalpha protein, humanMutL Protein Homolog 1MutL ProteinsNuclear ProteinsPms2 protein, mouse

Identifiers

PMID24971578
PMCPMC4074104
OpenAlexW2119221568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.